March 11, 2005 -- The U.S. Food and Drug Administration (FDA) has warned healthcare professionals and patients via public health advisory of the potential cancer risk associated with use of ...
Two eczema creams — Novartis AG’s Elidel and Fujisawa Healthcare, Inc.’s Protopic, must carry a strong warning of cancer risk, the Food and Drug Administration said Thursday. Research shows the creams ...
SaveHealth reports on eczema medications, detailing various options from topical treatments to advanced therapies for ...
Jan. 19, 2006 — The US Food and Drug Administration (FDA) has approved revisions to the safety labeling for 1% pimecrolimus cream ( Elidel, made by Novartis Pharmaceuticals Corporation) and tacrolimus ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In 2006, when the FDA instilled black box warnings on ...
The FDA has added black box warnings to two eczema treatments--Elidel, made by Novartis, and Protopic, made by Japan's Astellas Pharma. The new labels warn that these treatments are linked to an ...
The labels on two prescription creams to treat eczema will have to bear “black box” warnings of possible cancer risks. The Food and Drug Administration action on Thursday follows an agency advisory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback